subject area of
- A therapeutic alternative for haemophiliacs with inhibitors Journal Articles
- Age‐related changes in factor VII proteolysis in vivo Journal Articles
- Altered regulation of in-vivo coagulation in orthopedic patients prior to knee or hip replacement surgery Journal Articles
- An illustrative case and a review on the dosing of recombinant factor VIIa in congenital factor XI deficiency Journal Articles
- Analysis of Inhibition Rate Enhancement by Covalent Linkage of Antithrombin to Heparin as a Potential Predictor of Reaction Mechanism Journal Articles
- Can activated recombinant factor VII be used to postpone the exposure of infants to factor VIII until after 2 years of age? Journal Articles
- Comprehensive Canadian Review of the Off-Label Use of Recombinant Activated Factor VII in Cardiac Surgery Journal Articles
- Continuous Infusion of Recombinant Factor VIIa in Hemophilic Patients with Inhibitors: Safety, Monitoring, and Cost Effectiveness Journal Articles
- Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII Journal Articles
- D-dimer and factor VIIa in atrial fibrillation – prognostic values for cardiovascular events and effects of anticoagulation therapy Journal Articles
- Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding Journal Articles
- Dose-Response Study of Recombinant Factor VIIa/Tissue Factor Inhibitor Recombinant Nematode Anticoagulant Protein c2 in Prevention of Postoperative Venous Thromboembolism in Patients Undergoing Total Knee Replacement Journal Articles
- Effect of heparins on thrombin generation in hemophilic plasma supplemented with FVIII, FVIIa, or FEIBA. Journal Articles
- Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: An individual patient based meta-analysis of two controlled trials Journal Articles
- Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers Journal Articles
- Experiences with continuous infusion of recombinant activated factor VII. Conferences
- Factor VIIa gets even bigger Journal Articles
- Feasibility of Using Recombinant Factor VIIa in Continuous Infusion Journal Articles
- How I treat target-specific oral anticoagulant–associated bleeding Journal Articles
- Iatrogenic causes of an ICH Journal Articles
- Influence of activated factor VII concentrates on thrombin generation in full-term and preterm neonates Journal Articles
- Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns Journal Articles
- LETTERS TO THE EDITOR Journal Articles
- Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia Journal Articles
- Management of Excessive Anticoagulant Effect Due to Vitamin K Antagonists Journal Articles
-
Methodologies for data collection in congenital haemophilia with inhibitors (
CH wI): critical assessment of the literature and lessons learned from recombinant factorVII a Journal Articles - Neutralization of Heparin Activity Journal Articles
- New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management Conferences
- New Anticoagulant Therapy Journal Articles
- Off-label use of recombinant activated factor VII in surgical and non-surgical patients at 16 Canadian hospitals from 2007 to 2010 (Canadian Registry Report) Journal Articles
- On-Label Versus Off-Label Use of Recombinant Activated Factor VII: A Comprehensive Review of Use in Two Canadian Centers Journal Articles
- Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care Journal Articles
- Probable regulation of factor VIIa–tissue factor and prothrombinase by factor Xa–TFPI and TFPI in vivo Journal Articles
- Recombinant FVIIa in children with liver disease Journal Articles
- Recombinant Factor VIIa in Multiple Surgery Journal Articles
- Recombinant activated factor VII for the treatment of life-threatening haemorrhage Journal Articles
- Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding Journal Articles
- Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors Journal Articles
- Reversal of New, Factor-specific Oral Anticoagulants by rFVIIa, Prothrombin Complex Concentrate and Activated Prothrombin Complex Concentrate: A Review of Animal and Human Studies Journal Articles
- Reversing Anticoagulant Therapy Journal Articles
- Reversing anticoagulants both old and new. Journal Articles
- Review of pumps for continuous infusion of coagulation factor concentrates: what are the options? Conferences
- SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMY Journal Articles
- Safety, efficacy and lessons from continuous infusion with rFVIIa Conferences
- Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI Group. Journal Articles
- Successful treatment with rFVIIa of spontaneous intracerebral hemorrhage in a patient with mechanical prosthetic heart valves Journal Articles
- The M358R variant of α 1 -proteinase inhibitor inhibits coagulation factor VIIa Journal Articles
- The onerous task of comparing treatments in inhibitor patients Journal Articles
- The role of recombinant factor VIIa in on-pump cardiac surgery: Proceedings of the Canadian Consensus Conference Journal Articles
- Thrombin generation in vitro in the presence of by‐passing agents in siblings with severe haemophilia A Journal Articles
- Time Course of Early Hematoma Expansion in Acute Spot-Sign Positive Intracerebral Hemorrhage: Prespecified Analysis of the SPOTLIGHT Randomized Clinical Trial Journal Articles
- Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia Journal Articles
- We Need Both Evidence and Values to Navigate Uncertainty Journal Articles
- What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin? Journal Articles
- Zinc: An important cofactor in haemostasis and thrombosis Journal Articles